Development and testing of advanced methods for the screening of Enhanced-Oil-Recovery techniques

Enhanced Oil Recovery (EOR) techniques must undergo preliminary laboratory and pilot testing before implementation to field-wide scale, and the whole evaluation process requires heavy investments. Hence forecasting EOR potential is a key decision-making element. A critical difference amongst EOR techniques resides in the oil-displacement mechanism upon which they are based. The effectiveness of these mechanisms depends on oil and reservoir properties. As such, similar EOR techniques are typically successful in fields sharing similar features. Here we implement and test a screening method aimed at estimating the optimal EOR technique for a target reservoir. Our approach relies on the information content tied to an exhaustive set of EOR field experiences. The basic screening criterion is the analogy with known reservoir settings in terms of oil and formation properties. Analogy is assessed by grouping fields into clusters: we rely on a Bayesian hierarchical clustering algorithm, whose main advantage is that the number of clusters is not set a priori but stems from data statistics. As a test bed, we perform a blind test of our screening approach by considering 2 fields operated by eni. Our predictions for analogy assessment are in agreement with the EOR techniques applied or planned in these fields

A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression

BACKGROUND: Acromegaly is a rare disease associated with an increased risk of developing cancer. CASE PRESENTATION: We report the case of a 72-year-old man who was diagnosed with acromegaly (IGF-1 770 ng/ml) and breast cancer. Four years before he suffered from a colon-rectal cancer. Pituitary surgery and octreotide-LAR treatment failed to control acromegaly. Normalization of IGF-1 (97 ng/ml) was obtained with pegvisomant therapy. Four years after breast cancer surgery, 2 pulmonary metastases were detected at chest CT. The patient was started on anastrozole, but, contrary to medical advice, he stopped pegvisomant treatment (IGF-I 453 ng/ml). Four months later, chest CT revealed an increase in size of the metastatic lesion of the left lung. The patient was shifted from anastrozole to tamoxifen and was restarted on pegvisomant, with normalization of serum IGF-1 levels (90 ng/ml). Four months later, a reduction in size of the metastatic lesion of the left lung was detected by CT. Subsequent CT scans throughout a 24-month follow-up showed a further reduction in size and then a stabilization of the metastasis. CONCLUSIONS: This is the first report of a male patient with acromegaly and breast cancer. The clinical course of breast cancer was closely related to the metabolic control of acromegaly. The rapid progression of metastatic lesion was temporally related to stopping pegvisomant treatment and paralleled a rise in serum IGF-1 levels. Normalization of IGF-1 after re-starting pegvisomant impressively reduced the progression of metastatic breast lesions. Control of acromegaly is mandatory in acromegalic patients with cancer

Lithuania

This report is part of the project The Factbook on the Illicit Trade in Tobacco Products(henceforth ITTP)

Dynamics of antiproton cooling in a positron plasma during antihydrogen formation

Abstract We demonstrate cooling of 10 4 antiprotons in a dense, cold plasma of ∼10 8 positrons, confined in a nested cylindrical Penning trap at about 15 K. The time evolution of the cooling process has been studied in detail, and several distinct types of behavior identified. We propose explanations for these observations and discuss the consequences for antihydrogen production. We contrast these results with observations of interactions between antiprotons and "hot" positrons at about 3000 K, where antihydrogen production is strongly suppressed

Protonium production in ATHENA

Abstract The ATHENA experiment at CERN, after producing cold antihydrogen atoms for the first time in 2002, has synthesised protonium atoms in vacuum at very low energies. Protonium, i.e. the antiproton–proton bound system, is of interest for testing fundamental physical theories. In the nested penning trap of the ATHENA apparatus protonium has been produced as result of a chemical reaction between an antiproton and the simplest matter molecule, H 2 + . The formed protonium atoms have kinetic energies in the range 40–700 meV and are metastable with mean lifetimes of the order of 1 μs. Our result shows that it will be possible to start measurements on protonium at low energy antiproton facilities, such as the AD at CERN or FLAIR at GSI

Technical Design Report for the PANDA Solenoid and Dipole Spectrometer Magnets

This document is the Technical Design Report covering the two large spectrometer magnets of the PANDA detector set-up. It shows the conceptual design of the magnets and their anticipated performance. It precedes the tender and procurement of the magnets and, hence, is subject to possible modifications arising during this process.Comment: 10 pages, 14MB, accepted by FAIR STI in May 2009, editors: Inti Lehmann (chair), Andrea Bersani, Yuri Lobanov, Jost Luehning, Jerzy Smyrski, Technical Coordiantor: Lars Schmitt, Bernd Lewandowski (deputy), Spokespersons: Ulrich Wiedner, Paola Gianotti (deputy

Measuring the free fall of antihydrogen

After the first production of cold antihydrogen by the ATHENA and ATRAP experiments ten years ago, new second-generation experiments are aimed at measuring the fundamental properties of this anti-atom. The goal of AEGIS (Antimatter Experiment: Gravity, Interferometry, Spectroscopy) is to test the weak equivalence principle by studying the gravitational interaction between matter and antimatter with a pulsed, cold antihydrogen beam. The experiment is currently being assembled at CERN's Antiproton Decelerator. In AEGIS, antihydrogen will be produced by charge exchange of cold antiprotons with positronium excited to a high Rydberg state (n > 20). An antihydrogen beam will be produced by controlled acceleration in an electric-field gradient (Stark acceleration). The deflection of the horizontal beam due to its free fall in the gravitational field of the earth will be measured with a moire deflectometer. Initially, the gravitational acceleration will be determined to a precision of 1%, requiring the detection of about 105 antihydrogen atoms. In this paper, after a general description, the present status of the experiment will be reviewed

Production of He-4 and (4) in Pb-Pb collisions at root(NN)-N-S=2.76 TeV at the LHC

Results on the production of He-4 and (4) nuclei in Pb-Pb collisions at root(NN)-N-S = 2.76 TeV in the rapidity range vertical bar y vertical bar <1, using the ALICE detector, are presented in this paper. The rapidity densities corresponding to 0-10% central events are found to be dN/dy4(He) = (0.8 +/- 0.4 (stat) +/- 0.3 (syst)) x 10(-6) and dN/dy4 = (1.1 +/- 0.4 (stat) +/- 0.2 (syst)) x 10(-6), respectively. This is in agreement with the statistical thermal model expectation assuming the same chemical freeze-out temperature (T-chem = 156 MeV) as for light hadrons. The measured ratio of (4)/He-4 is 1.4 +/- 0.8 (stat) +/- 0.5 (syst). (C) 2018 Published by Elsevier B.V.Peer reviewe